Zafrens is a drug discovery company that specializes in a high-throughput, high-resolution Z-Screen™ platform for analyzing CRISPR, CAR-T, mRNA libraries, and molecular heterogeneity, aiming to develop RNA-modulatory small molecules and TCR libraries for cancer treatment and seeking partnerships to expand its technology's applications.

LyGenesis is a biotechnology company that uses lymph nodes as bioreactors to grow ectopic organs, with the potential to transform the treatment of multiple diseases.

Lyten is an EV battery startup that develops lightweight, energy-efficient, and environmentally friendly lithium-sulfur batteries, and is also involved in the development of IoT sensors.